Companies: 10,795·Total market cap: $144.5T

Tourmaline Bio, Inc.

Tourmaline Bio, Inc.

TRMLNASDAQHealthcare

$47.98

+$0.00(+0.00%)

Market Cap$1.2B

P/E Ratio—

52W High$48.27

52W Low$11.56

Avg Volume926K

Open$47.98

Beta1.58

Tourmaline Bio, Inc. (TRML) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

TRML · net income · updated Jun 9, 2026

Core profitability metrics

TRML · net income · margin · TTM · CAGR

Net income was −$73.2M for FY2024 (fiscal year ending 2024-12-31), down 73.8% year-over-year. Net profit margin was —.

FY2024 Net Income−$73.2M▼ -73.8% YoY

Trailing 12M (TTM)−$88.5Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change-73.8%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · TRML net income history · TRML profit margin

Annual net income data

TRML · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2024Loss−$73.2M▼ 73.8%—$0

FY2023Loss−$42.1M▼ 113.8%—$0

FY2022Loss−$19.7M▼ 2179214.2%—$0

FY2021Loss−$904▲ +100.0%—$0

FY2020Loss−$22.7M▼ 25.1%—$0

Net income vs peers (Healthcare)

TRML vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Tourmaline Bio, Inc.YOU

TRML

−$73.2M-73.8%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Tourmaline Bio, Inc. (TRML) reported net income of −$73.2M for FY2024 (fiscal year ending 2024-12-31), down 73.8% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Tourmaline Bio, Inc. has not yet achieved annual profitability based on available data (6 fiscal years). The company has reported net losses across all available periods.

Tourmaline Bio, Inc.'s net profit margin was — for FY2024, based on the latest annual results.

Investors sometimes search for "Tourmaline Bio, Inc. net worth" — the company's market capitalization is a separate figure from TRML net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

TRML net income · 4 questions

Tourmaline Bio, Inc. is not currently profitable on an annual basis. The company reported a net loss of $73.2M for FY2024.

is TRML profitabledoes TRML make a profitTRML profitabilityTRML profitable company

▸ Source: FMP /income-statement · GAAP · Tourmaline Bio, Inc. · Tourmaline Bio, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026